Comorbid depression among untreated illicit opiate users: Results from a multisite Canadian study

Canadian Journal of Psychiatry

Volumn 50, Issue 9, 2005, Pages 512-518

  Cameron Wild, T ^a   El Guebaly, Nady ^b,c   Fischer, Benedickt ^d,e   Brissette, Suzanne ^f,g   Brochu, Serge ^g   Bruneau, Julie ^g,h   Noël, Lina ⁱ   Rehm, Jürgen ^d,e   Tyndall, Mark ^j,k   Mun, Phil ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF MONTREAL   (Canada)

ⁱ Institut National de la Santé Publique du Québec   (Canada)

^j BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Depression; Injection drug use; Opiate use; Risk behaviour

Indexed keywords

COCAINE; OPIATE;

ADULT; ARTICLE; CANADA; CHI SQUARE DISTRIBUTION; CITY; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; INJECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HEALTH SERVICE; OPIATE ADDICTION; PREDICTION; PSYCHOLOGIC TEST; SAMPLE; SEX DIFFERENCE; SOCIAL ASPECT; URBAN POPULATION; WHITE ADIPOSE TISSUE;

EID: 31544475413     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674370505000903     Document Type: Article

References (34)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, and others. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA 1990;21:2511-8.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshelman S, and others. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994;51:8-19.
3. WHO/International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ 2000;78:413-26.
4. Kessler RC. Psychiatric epidemiology: Selected recent advances and future directions. Bull World Health Organ 2000;78:464-74.
5. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental health disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17-31.
6. Graaf RD, Bijl RV, Smit F, Vollegergh WAM, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and incidence study. Am J Psychiatry 2002;159:620-9.
7. Kessler RC, Crum, RM, Warner, LA, Nelson, CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1998;53:313-21.
8. Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, and others. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998;23:893-907.
9. Farrell M, Howes S, Taylor C, Lewis G, Jenkins R, Bebbington P, and others. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Addict Behav 1998;23:909-18.
10. Offord DR, Boyle MH, Campbell D, Goering P, Lin E, Wong M, and others. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 1997;41:59-63.
11. Bland RC, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand 1988;Suppl 338:24-32.
12. Skinstad AH, Swain A. Comorbidity in a clinical sample of substance abusers. Am J Drug Alcohol Abuse 2001;27:45-64.
13. Compton WM III, Cottler LB, Abdallah BA, Phelps DL, Spitznagel EL, Horton JC. Substance dependence and other psychiatric disorders among drug dependent subjects: race and gender correlates. Am J Addictions 2000;9:113-25.
14. Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997;54:71-80.
15. Rounsaville BJ, Weissman MM, Kleber H, Wilber C. Heterogeneity of psychiatric diagnosis in treated opiate addicts. Arch Gen Psychiatry 1982;39:161-8.
16. Rounsaville BJ, Kleber H, Wilber C. Untreated opiate addicts. Arch Gen Psychiatry 1985;42:1072-7.
17. Dinwiddie SH, Reich T, Cloninger CR. Psychiatric comorbidity and suicidality among intravenous drug users. J Clin Psychiatry 1992;53:364-9.
18. Lipsitz JD, Williams JBW, Rabkin JG, Remien RH, Bradbury M, El Sadr W, and others. Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry 1994;151:1662-8.
19. Knowlton AR, Latkin CA, Schroeder JR, Hoover DR, Ensminger M, Celentano DD. Longitudinal predictors of depressive symptoms among low income injection drug users. AIDS Care 2001;13:549-59.
20. Compton WM III, Cottler LB, Abdallah BA, Phelps DL, Spitznagel EL, Horton JC. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addictions 2000;9:126-34.
21. Stein MD, Solomon DA, Herman DS, Anthony JL, Ramsey SE, Anderson BJ, and others. Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users. Arch Gen Psychiatry 2004;61:152-9.
22. Brewer DD, Catalano RF, Haggerty K, Gainey RR, Fleming CB. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 1998;93:73-92.
23. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986;43:733-8.
24. Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts: course and relationship to treatment. Arch Gen Psychiatry 1982;39:151-6.
25. Metzger D, Woody G, De Philippis D, McLellan AT, O'Brien CP, Platt JJ. Risk factors for needle sharing among methadone-treated patients. Am J Psychiatry 1991;148:636-40.
26. Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse 1999;25:117-27.
27. Leri F, Bruneau J, Stewart J. Understanding polydrug use: review of heroin and cocaine co-use. Addiction 2003;98:7-22.
28. Bernard HR. Social research methods. Thousand Oaks (CA): Sage; 1999.
29. Barrett C, Good C, Moore C. Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. Forensic Sci Int 2001;122:163-6.
30. Kessler RC, Andrews G, Mroczek DK, Üstün TB, Wittchen HU. The World Health Organization Composite International Diagnostic Interview Short Form (CIDI-SF). Int J Methods Psychiatr Res 1998;7:171-85.
31. Beaudet MP. Depression. Health Rep 1996;7:11-24.
32. Isometsa ET, Aro H. Depression in Finland: a computer assisted telephone interview study. Acta Psychiatr Scand 1997;96:122-8.
33. Patten SB, Brandon-Christie J, Devji J, Sedmak B. Performance of the Composite International Diagnostic Interview Short Form for Major Depression in a community sample. Chronic Dis Can 2000;21:68-72.
34. Leri F, Stewart J, Fischer B, Rehm J, Marsh DC, Brissette S, and others. Patterns of opioid and cocaine co-use: a descriptive study of a Canadian sample of untreated opiate-dependent individuals. Experimental and Clinical Psychopharmacology. Forthcoming.